Maes HH - Search Results

1

Protection by L-2-oxothiazolidine-4-carboxylic acid of hydrogen peroxide-induced CD3zeta and CD16zeta chain down-regulation in human peripheral blood lymphocytes and lymphokine-activated killer cells.

Corsi MM, Maes HH, Wasserman K, Fulgenzi A, Gaja G, Ferrero ME. Corsi MM, et al. Among authors: maes hh. Biochem Pharmacol. 1998 Sep 1;56(5):657-62. doi: 10.1016/s0006-2952(98)00085-9. Biochem Pharmacol. 1998. PMID: 9783734

2

Generation and function of bone marrow-derived dendritic cells from CD4/CD8(-/-) double-knockout mice.

Corsi MM, Sandberg JK, Wasserman K, Maes HH, Kiessling R. Corsi MM, et al. Among authors: maes hh. Immunol Lett. 1999 Apr 15;67(3):243-9. doi: 10.1016/s0165-2478(99)00018-8. Immunol Lett. 1999. PMID: 10369133

3

Conversion of in vitro cultured human monocytes into effective presenters of an HER2/neu-encoded CTL peptide epitope.

Wasserman K, Corsi MM, Szekel L, Kono K, Maes HH, Kiessling R. Wasserman K, et al. Among authors: maes hh. Scand J Immunol. 1997 Jun;45(6):678-82. doi: 10.1046/j.1365-3083.1997.d01-450.x. Scand J Immunol. 1997. PMID: 9201308 Free article.

4

Interferon gamma impairs the ability of monocyte-derived dendritic cells to present tumour-specific and allo-specific antigens and reduces their expression of CD1A, CD80 AND CD4.

Rongcun Y, Maes H, Corsi M, Dellner F, Wen T, Kiessling R. Rongcun Y, et al. Cytokine. 1998 Oct;10(10):747-55. doi: 10.1006/cyto.1998.0357. Cytokine. 1998. PMID: 9811527

5

Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells.

Martin S, Dudek-Perić AM, Maes H, Garg AD, Gabrysiak M, Demirsoy S, Swinnen JV, Agostinis P. Martin S, et al. Biochem Pharmacol. 2015 Feb 1;93(3):290-304. doi: 10.1016/j.bcp.2014.12.003. Epub 2014 Dec 18. Biochem Pharmacol. 2015. PMID: 25529535 Free article.

6

Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas.

Rongcun Y, Salazar-Onfray F, Charo J, Malmberg KJ, Evrin K, Maes H, Kono K, Hising C, Petersson M, Larsson O, Lan L, Appella E, Sette A, Celis E, Kiessling R. Rongcun Y, et al. J Immunol. 1999 Jul 15;163(2):1037-44. J Immunol. 1999. PMID: 10395702

7

Cancer prevention by adoptive transfer of antigen 60-activated immunocompetent cells.

Maes H, Cocito C. Maes H, et al. Scand J Immunol. 1996 Mar;43(3):283-8. doi: 10.1046/j.1365-3083.1996.d01-37.x. Scand J Immunol. 1996. PMID: 8602462

8

Synthesis of cytokines during tumour development in mice immunized with the mycobacterial antigen complex A60.

Maes H, Cocito C. Maes H, et al. Scand J Immunol. 1996 Oct;44(4):369-74. doi: 10.1046/j.1365-3083.1996.d01-318.x. Scand J Immunol. 1996. PMID: 8845030

9

Tuberculosis I: a conceptual frame for the immunopathology of the disease.

Maes HH, Causse JE, Maes RF. Maes HH, et al. Among authors: maes rf. Med Hypotheses. 1999 Jun;52(6):583-93. doi: 10.1054/mehy.1997.0698. Med Hypotheses. 1999. PMID: 10459843

10

Alteration of the immune response during cancer development and prevention by administration of a mycobacterial antigen.

Maes H, Taper H, Cocito C. Maes H, et al. Scand J Immunol. 1995 Jan;41(1):53-64. doi: 10.1111/j.1365-3083.1995.tb03533.x. Scand J Immunol. 1995. PMID: 7824889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters